Pharmaceutical biotechnology fundamentals and applications

Pharmaceutical biotechnology fundamentals and applications

Show other versions (1)

Completely revised text that reflects to emergent trends and cutting-edge advances in pharmaceutical biotechnology, this Third Edition provides a well-balanced framework for understanding every major aspect of pharmaceutical biotechnology, including drug development, production, dosage forms, admini...

Full description

Saved in:
Bibliographic Details
Other Authors: Daan J. A. Crommelin (Editor), Crommelin, D. J. A. Daan J. A., Sindelar, Robert D. Daan J. A., Meibohm, Bernd
Format: Book
Language:English
Published: New York Informa Healthcare ©2008
Edition:Third Edition
Subjects:
Technology, Pharmaceutical
Online Access:Click Here to View Status and Holdings.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000cam a2200000#i 4501
001 wils-395548
005 202482165842
008 t ag# ##001 ##eng#D
020 # # |a 9781420067521  |q hardback 
022 # # |a 1420067524  |y hardback 
040 # # |a DLC  |b eng  |d UiTM  |e rda 
041 0 # |a eng 
060 0 0 |a QV778 
090 0 0 |a QV778  |b P5351 2008 
100 1 # |a Daan J. A. Crommelin  |e editor 
245 0 0 |a Pharmaceutical biotechnology  |b fundamentals and applications  |c edited by Daan J.A. Crommelin, Robert D. Sindelar, Bernd Meibohm 
250 # # |a Third Edition 
264 # 1 |a New York  |b Informa Healthcare  |c ©2008 
300 # # |a xiv, 466 p.  |b ill.  |c 27 cm 
336 # # |a text  |2 rdacontent 
337 # # |a unmediated  |2 rdamedia 
338 # # |a volume  |2 rdacarrier 
504 # # |a Includes bibliographical references and index 
520 # # |a Completely revised text that reflects to emergent trends and cutting-edge advances in pharmaceutical biotechnology, this Third Edition provides a well-balanced framework for understanding every major aspect of pharmaceutical biotechnology, including drug development, production, dosage forms, administration, and therapeutic developments. New chapters cover evolving areas regarding biopharmaceuticals, including oligonucleotides, siRNA and various monoclonal antibodies, immunogenicity, gene therapy, and the regulatory issues factoring into the biopharmaceutical approval process 
650 # 0 |a Technology, Pharmaceutical 
700 1 # |a Crommelin, D. J. A.  |q Daan J. A. 
700 # # |a Sindelar, Robert D.  |q Daan J. A. 
700 # # |a Meibohm, Bernd 
856 4 0 |z Click Here to View Status and Holdings.  |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=395548 
964 # # |c BOK  |d MD 
998 # # |a 00250##a002.5.2||00250##b002.5.3||00264#1a002.8.2||00264#1b002.8.4||00300##a003.4.1||00300##b003.6.1||00300##c003.5.1||00520##a007.2||00520##b007.2||01700##a0011.2.2||01700##q0017.8||02700##a0011.2.2|| 

Similar Items